Christopher Tovey
Chief Executive Officer chez DESTINY PHARMA PLC
Profil
Christopher John Tovey est actuellement directeur de l'exploitation chez GW Pharmaceuticals Plc. Il est également membre du conseil d'administration de CanImGuide Therapeutics AB, GW Research Ltd. et GW Pharma Ltd. M. Tovey a précédemment occupé le poste de directeur de l'unité commerciale Vaccins chez GlaxoSmithKline Plc et celui de vice-président des opérations marketing mondiales chez UCB SA. Il a obtenu un diplôme de premier cycle à l'Université de Liverpool.
Postes actifs de Christopher Tovey
| Sociétés | Poste | Début |
|---|---|---|
| DESTINY PHARMA PLC | Chief Executive Officer | 01/09/2023 |
GW Research Ltd.
 GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Director/Board Member | 01/10/2012 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
GW Pharma Ltd.
 GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Director/Board Member | 01/10/2012 |
Anciens postes connus de Christopher Tovey
| Sociétés | Poste | Fin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 01/10/2022 |
| GW PHARMACEUTICALS PLC | Chief Operating Officer | - |
| UCB | Corporate Officer/Principal | 01/09/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2005 |
Formation de Christopher Tovey
| The University of Liverpool | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GSK PLC | Health Technology |
| UCB | Health Technology |
| DESTINY PHARMA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Commercial Services |
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Health Technology |
